CorMedix (CRMD) PT Lowered to $19 at JMP Securities, Following Regulatory Business Update
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Price: $8.23 +0.73%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
JMP Securities analyst Jason N. Butler lowered the price target on CorMedix (NASDAQ: CRMD) to $19.00 (from $22.00) while maintaining a Market Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Citi Downgrades Ecopetrol SA (EC) to Neutral
- Otsuka Holdings Co Ltd. (4578:JP) (OTSKY) PT Raised to JPY11,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
